McMahon, Sean R.
Chava, Sreedivya
Taatjes-Sommer, Heidi S.
Meagher, Sean
Brummel-Ziedins, Kathleen E.
Schneider, David J.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Variation in platelet expression of FcγRIIa after myocardial infarction
https://doi.org/10.1007/s11239-019-01852-7
Funding for this research was provided by:
Janssen Pharmaceuticals
Article History
First Online: 9 April 2019
Compliance with ethical standards
:
: David J Schneider is named inventor on a pending patent application (Application No.: 14/403,337) that proposes the use of FcγRIIa for assaying platelet reactivity and treatment selection. The remaining authors have no disclosure.